Sheeba Irshad MD, PhD

Dr. Irshad is a clinician-scientist and practicing breast Medical Oncologist trained in tumour immunology. She is currently a clinical reader at King’s College London and has established an independent group focused on understanding the immune landscape of chemotherapy resistant breast cancers. She has led multidisciplinary laboratory/clinical teams addressing biomarker and therapy development in high-risk breast cancer leading to senior author publications in Cancer Cell, Lancet Oncology, and Clinical Cancer Research. She is also the Deputy Director in KCL/ICR Integrated Breast Cancer Now Programme, directing the KCL Research Unit and its breast cancer immunobiology focussed programme. She is also part of an international team that have recently been awarded the 2024 CRUK Grand Challenge which aims to investigate Societal, Ancestry, Molecular and Biological Analyses of Inequalities (SAMBAI).